[English] 日本語
Yorodumi- EMDB-51513: PbuCas13b Helical-2 domain in complex with anti-CRISPR protein (A... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | PbuCas13b Helical-2 domain in complex with anti-CRISPR protein (AcrVIB1) | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | AcrVIB1 / anti-CRISPR protein / Cas13b / RNA BINDING PROTEIN | |||||||||
| Biological species | Segatella buccae (bacteria) / Riemerella anatipestifer (bacteria) | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 5.11 Å | |||||||||
Authors | Schmelz S / Lukat P / Blankenfeldt W | |||||||||
| Funding support | 1 items
| |||||||||
Citation | Journal: Mol Cell / Year: 2025Title: AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack. Authors: Katharina G Wandera / Stefan Schmelz / Angela Migur / Anuja Kibe / Peer Lukat / Tatjana Achmedov / Neva Caliskan / Wulf Blankenfeldt / Chase L Beisel / ![]() Abstract: Anti-CRISPR proteins (Acrs) inhibit CRISPR-Cas immune defenses, with almost all known Acrs acting on the Cas nuclease-CRISPR (cr)RNA ribonucleoprotein (RNP) complex. Here, we show that AcrVIB1 from ...Anti-CRISPR proteins (Acrs) inhibit CRISPR-Cas immune defenses, with almost all known Acrs acting on the Cas nuclease-CRISPR (cr)RNA ribonucleoprotein (RNP) complex. Here, we show that AcrVIB1 from Riemerella anatipestifer, the only known Acr against Cas13b, principally acts upstream of RNP complex formation by promoting unproductive crRNA binding followed by crRNA degradation. AcrVIB1 tightly binds to Cas13b but not to the Cas13b-crRNA complex, resulting in enhanced rather than blocked crRNA binding. However, the more tightly bound crRNA does not undergo processing and fails to activate collateral RNA cleavage even with target RNA. The bound crRNA is also accessible to RNases, leading to crRNA turnover in vivo even in the presence of Cas13b. Finally, cryoelectron microscopy (cryo-EM) structures reveal that AcrVIB1 binds a helical domain of Cas13b responsible for securing the crRNA, keeping the domain untethered. These findings reveal an Acr that converts an effector nuclease into a crRNA sink to suppress CRISPR-Cas defense. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_51513.map.gz | 12 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-51513-v30.xml emd-51513.xml | 18.3 KB 18.3 KB | Display Display | EMDB header |
| Images | emd_51513.png | 106.9 KB | ||
| Filedesc metadata | emd-51513.cif.gz | 5.5 KB | ||
| Others | emd_51513_half_map_1.map.gz emd_51513_half_map_2.map.gz | 12 MB 12 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-51513 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-51513 | HTTPS FTP |
-Validation report
| Summary document | emd_51513_validation.pdf.gz | 684.7 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_51513_full_validation.pdf.gz | 684.3 KB | Display | |
| Data in XML | emd_51513_validation.xml.gz | 9.3 KB | Display | |
| Data in CIF | emd_51513_validation.cif.gz | 10.8 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-51513 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-51513 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_51513.map.gz / Format: CCP4 / Size: 12.9 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.91 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #1
| File | emd_51513_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_51513_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : PbuCas13b Helical-2 domain in complex with AcrVIB1
| Entire | Name: PbuCas13b Helical-2 domain in complex with AcrVIB1 |
|---|---|
| Components |
|
-Supramolecule #1: PbuCas13b Helical-2 domain in complex with AcrVIB1
| Supramolecule | Name: PbuCas13b Helical-2 domain in complex with AcrVIB1 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Source (natural) | Organism: Segatella buccae (bacteria) |
-Macromolecule #1: PbuCas13b Helical-2 domain
| Macromolecule | Name: PbuCas13b Helical-2 domain / type: protein_or_peptide / ID: 1 / Details: PbuCas13b Helical-2 domain (residues 579 - 747) / Enantiomer: DEXTRO |
|---|---|
| Source (natural) | Organism: Segatella buccae (bacteria) |
| Recombinant expression | Organism: ![]() |
| Sequence | String: GGGRRCKDMG KEAE RKIGE MIDDTQRRLD LLCKQTNQKI RIGKRNAGLL KSGKI ADWL VNDMMRFQPV QKDQNNIPIN NSKANSTEYR MLQRAL ALF GSENFRLKAY FNQMNLVGND NPHPFLAETQ WEHQTNI LS FYRNYLEARK KYLKGLKPQN WKQYQHFLIL KVQKCNR |
-Macromolecule #2: AcrVIB1
| Macromolecule | Name: AcrVIB1 / type: protein_or_peptide / ID: 2 / Enantiomer: DEXTRO |
|---|---|
| Source (natural) | Organism: Riemerella anatipestifer (bacteria) |
| Recombinant expression | Organism: ![]() |
| Sequence | String: GGGRMKDLDL SKLKGEEIAQ WLLNNKKA T AIQLSSERTD TDDGFMHILV HKDEYVEIIY SYLKIDEDD VMQNFTIYSK RWGNIDNSYF ELQTFEGEIF TGESDKILCG VLSLGDLTT LK |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 0.1 mg/mL |
|---|---|
| Buffer | pH: 7 / Details: 20mM HEPES pH7.5 150 mM NaCl |
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 200 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 100 sec. / Pretreatment - Atmosphere: AIR / Pretreatment - Pressure: 4.0 kPa |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 283 K / Instrument: FEI VITROBOT MARK IV |
| Details | The SEC co-purified complex of PbuCas13b_ Helical-2:AcrVIB1 was diluted to 0.1 mg/ml and used for grid preparation |
-
Electron microscopy
| Microscope | TFS GLACIOS |
|---|---|
| Specialist optics | Energy filter - Name: TFS Selectris / Energy filter - Slit width: 10 eV |
| Software | Name: EPU (ver. 3.3.1.5184) |
| Image recording | Film or detector model: TFS FALCON 4i (4k x 4k) / Number real images: 10707 / Average electron dose: 60.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | C2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 1.6 µm / Nominal defocus min: 0.6 µm |
| Sample stage | Cooling holder cryogen: NITROGEN |
-
Image processing
| Startup model | Type of model: INSILICO MODEL / Details: insilco model generated with cryoSPARC in C1 |
|---|---|
| Final reconstruction | Applied symmetry - Point group: C1 (asymmetric) / Resolution.type: BY AUTHOR / Resolution: 5.11 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cryoSPARC (ver. v4.5.3) / Number images used: 1078020 |
| Initial angle assignment | Type: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. v4.5.3) |
| Final angle assignment | Type: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC (ver. v4.5.3) |
Movie
Controller
About Yorodumi



Keywords
Segatella buccae (bacteria)
Authors
Citation



Z (Sec.)
Y (Row.)
X (Col.)




































FIELD EMISSION GUN